Looking for a Big Start to the Week

The Clorox Co. CLX – Recap

Our sole fresh options trading idea on Friday was in the CLX chain and came on the heels of the company’s earnings drop. Bleach definitely has a big role to play during the coronavirus pandemic based on a need to keep surfaces as disinfected as possible, making this a high synergy play.

The single-session gains our idea produced during Friday’s session are certainly indicative of that, with huge multi-bag rips across the board:

CLX Weekly $190-195 Calls
$190: .90-7.50 (+733%)
$192.50:  .63-5.69 (+801%)
$195: .41-3.33 (+712%)
_____

SPDR S&P500 (ETF) SPY – Recap

We also have the final highs and total ranges on the group of SPY Puts that we signaled in Thursday morning’s premarket report. Those also turned out to be a great success, with two-day moves which also reached multi-bag status.

SPY 05/04 $291-288 Puts
$291: 2.49-9.50 (+282%)
$290:  2.14-8.60 (+305%)
$289: 1.84-7.75 (+321%)
$288: 1.54-7.00 (+355%)


Fresh Options Ideas:
BUD 09/18 $45-55 Calls
STZ 07/17 $170-180 Calls
CGC Weekly $16-16.50 Calls
TLRY Weekly $7-7.50 Calls
TSN Weekly $57-55 Puts 


Extended Watchlist:
TGHI, GMEV, BYZN, WARM, RTTR, APDN, NNVC, YGYI, OGEN, PRTY

Blue Horseshoe Stocks: Bottom Play Alert, HEB & More

FBC Holdings, Inc. FBCD

We wanted send out an alert on FBCD this morning, if for no other reason than the fact that it’s been quite awhile since we found a bottom play trading near all-time lows in the super-subpenny range. We’ve definitely been known to do some bottom-fishing in our day, with some of our biggest wins coming from bargain shopping.

What we have in FBCD is a stock that has been beaten back to a record low of .0005 (reached yesterday) which catches our attention in a big way. We are going to stay vigilant as we monitor this play for a solid bottom, because a snapback to to the double-zero range is not only very possible, but also has the potential to happen quite rapidly.

With so little room to the downside, one might classify FBCD as a “lottery ticket” type of play. The action on super-subpennies have the potential to return exponential gains, which is why we’re going to give it a spot on our running watchlist.

A quick glance at the chart shows that each time an influx of volume has come into the stock, it makes a run to test its 50DMA. From present levels, a jump to the current 50DMA would mean a chance for gains of at least 66%


Hemishperx BioPharma, Inc. HEB

We were passively tracking HEB via our extended watchlist last month, and are going to keep giving it our attention as the new quarter kicks off today. The stock is gapping up to the tune of roughly 25% in the premarket.

We caught notice of HEB following the company’s announcement that it would collaborate with US Army Medical Research to develop treatments to attempt to overcome the emergence of drug resistance due to Ebola virus mutation.

With the current Ebola breakout making it a hot-button topic, and the company stating this week that it would be expanding its Ebola research, we’re going to still be keeping our ears to the ground on this one.


Spherix, Inc. SPEX

SPEX made an appearance in yesterday morning’s extended watchlist and had one heck of a solid session. The stock came out of the gate and ran from a low of .99 all the way up to 1.58, offering us the chance to bank up to 60% in profits as it traded more than 13.5X its 3-month average volume.

Disappointment over the delay of some upcoming litigation that Shperix has against VTech and Uniden (View PR) is the apparent cause of the stock’s gapping down in today’s premarket.


Extended Watchlist:
LAKE, BCRX, ANGI, RVP, NNVC, CGA

Blue Horseshoe Stocks: CBDE, MCPI News & More

CBD Energy Ltd. CBDE

CBDE is a fairly new issuer, and built some serious momentum off of its bottom on Friday after the announcement of a lucrative solar farm construction contract. The company reports expected pre-tax revenues from the project amounting to more than $6 Million to be recognized in 2015, so we’re going to place this new stock on our medium-to-long term watchlist.

In the meantime, CBDE appears to be on the cusp of breaking the $4-mark this morning, which is the level at which the stock began trading just a couple of months ago. We’ll be watching for a breach of this psychological barrier, which would effectively put CBDE in Blue Sky mode, with no telling where the ceiling might come.

It should make for an interesting story to follow in the days and weeks ahead.


Med-Cannabis Pharma, Inc. MCPI

Turning focus to the marijuana space, we’ve got a new play to add to our running watchlist. It’s most interesting to us because it has a part to play in the implementation of legalization in Washington, which has been much more subdued than Colorado’s roll-out.

The madness that ensued thereafter led to months of record-breaking gains, but at the same time led to an SEC crackdown on what had become a free-for-all of false claims and hysteria. For that reason, companies involved in the more slowly unfolding Washington cannabis industry have been fewer and further between.

That’s exactly why we want to keep an eye on MCPI moving forward, despite the fact that it has already seen exponential gains; it’s confirmed that the company actually has boots on the ground in Washington, as indicated in this morning’s press release that we think you’ll want to check out:

PORT TOWNSEND, WA, Aug 04, 2014 (Marketwired via COMTEX) — Med-Cannabis Pharma, Inc. (OTCQB: MCPI), a Nevada Company specializing in Medical cannabis sales will be opening several Medical cannabis stores through its subsidiary Cannabis Hemporium in various towns on the Olympic Peninsula in the State of Washington during the month of August. The towns include Port Townsend, Port Hadlock and the Hood Canal location where work has been continuing for opening. >>> FULL PR


Side Note:

On Friday, we mentioned that we had an interest in PBR $16 Calls for this week, so we just wanted to remind readers that we would be focusing on those contracts as the trading week commences.


Extended Watchlist:
TSEM, NNVC, MEET, NQ, CAMT